Prokidney

Industry · 10 registered clinical trials — 3 currently recruiting.

Status	Trial	Phase	Started
Withdrawn	A Study of Renal Autologous Cell Therapy (REACT) in Participants With Type 2 Diabetes and Chronic Kidney Disea Type 2 Diabetes Mellitus, Chronic Kidney Diseases	Phase 3	2024-07-17
Recruiting	A Long-Term Follow-Up Study of Participants Exposed to REACT Diabetic Kidney Disease, Chronic Kidney Diseases	—	2023-12-11
Enrolling By Invitation	Long-Term Follow-up Study of Participants Exposed to Renal Autologous Cell Therapy Frozen Product Diabetic Kidney Disease, Chronic Kidney Disease	—	2023-11-23
Terminated	A Study of Participants With Chronic Kidney Disease Previously Treated With REACT Diabetic Kidney Disease, CAKUT, Chronic Kidney Diseases	Phase 1	2023-07-11
Recruiting	Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease Type 2 Diabetes Mellitus, Chronic Kidney Diseases	Phase 3	2022-01-05
Completed	Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN- Chronic Kidney Diseases, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus	Phase 2	2021-07-27
Completed	A Study of a Renal Autologous Cell Therapy (REACT) in Patients With Chronic Kidney Disease (CKD) From Congenit Chronic Kidney Disease, Congenital Anomalies of Kidney and Urinary Tract	Phase 1	2019-08-13
Completed	A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease Type 2 Diabetes Mellitus, Chronic Kidney Disease	Phase 2	2018-04-25
Completed	A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease Type 2 Diabetes Mellitus, Chronic Kidney Disease	Phase 2	2016-09-01
Terminated	Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD) Chronic Kidney Disease, Type 2 Diabetes	Phase 2	2016-07-01